Skip to main content
Sleep logoLink to Sleep
. 2016 Nov 1;39(11):1951–1959. doi: 10.5665/sleep.6222

Aberrant Food Choices after Satiation in Human Orexin-Deficient Narcolepsy Type 1

Ruth Janke van Holst 1,2,3,, Lisa van der Cruijsen 2, Petra van Mierlo 4, Gert Jan Lammers 5,6, Roshan Cools 2,7, Sebastiaan Overeem 1,4,8,*, Esther Aarts 2,*
PMCID: PMC5070749  PMID: 27568806

Abstract

Study Objectives:

Besides influencing vigilance, orexin neurotransmission serves a variety of functions, including reward, motivation, and appetite regulation. As obesity is an important symptom in orexin-deficient narcolepsy, we explored the effects of satiety on food-related choices and spontaneous snack intake in patients with narcolepsy type 1 (n = 24) compared with healthy matched controls (n = 19). In additional analyses, we also included patients with idiopathic hypersomnia (n = 14) to assess sleepiness-related influences.

Methods:

Participants were first trained on a choice task to earn salty and sweet snacks. Next, one of the snack outcomes was devalued by having participants consume it until satiation (i.e., sensory-specific satiety). We then measured the selective reduction in choices for the devalued snack outcome. Finally, we assessed the number of calories that participants consumed spontaneously from ad libitum available snacks afterwards.

Results:

After satiety, all participants reported reduced hunger and less wanting for the devalued snack. However, while controls and idiopathic hypersomnia patients chose the devalued snack less often in the choice task, patients with narcolepsy still chose the devalued snack as often as before satiety. Subsequently, narcolepsy patients spontaneously consumed almost 4 times more calories during ad libitum snack intake.

Conclusions:

We show that the manipulation of food-specific satiety has reduced effects on food choices and caloric intake in narcolepsy type 1 patients. These mechanisms may contribute to their obesity, and suggest an important functional role for orexin in human eating behavior.

Clinical Trials Registration:

Study registered at Netherlands Trial Register. URL: www.trialregister.nl. Trial ID: NTR4508.

Citation:

van Holst RJ, van der Cruijsen L, van Mierlo P, Lammers GJ, Cools R, Overeem S, Aarts E. Aberrant food choices after satiation in human orexindeficient narcolepsy type 1. SLEEP 2016;39(11):1951–1959.

Keywords: orexin, over-eating, narcolepsy, habits, satiation, obesity


Significance.

Patients with orexin (hypocretin) deficient narcolepsy type 1 often suffer from obesity as well as increased food craving, in addition to sleep symptoms. However, the mechanisms underlying weight gain in narcolepsy are unclear. We employed an innovative cognitive behavioral design to provide, for the first time, experimental evidence that narcolepsy patients respond less to satiety to modify food choices and food intake, which might contribute to weight problems. These data suggest that—in line with previous animal studies—orexin signaling plays an important role in human food-related motivation. Therefore, our findings not only have relevance to eating behavior in narcolepsy, but also for human eating behavior in general, opening avenues for future research.

INTRODUCTION

The loss of orexin (hypocretin) neurons in lateral hypothalamus leads to narcolepsy type 1.1,2 In addition to the classic sleep symptoms, narcoleptic patients experience several non-sleep problems. For example, the incidence of obesity is twice as high in narcolepsy compared with the normal population.35 Narcolepsy has also been associated with an increased prevalence of eating disorders.6,7 Moreover, 50% of narcolepsy patients report a persisted craving for food as well as episodes of binge eating.7

Besides its role in the control of vigilance, orexin neuro-transmission is primarily important for mediating behavior under situations of high motivational relevance, including adapting homeostatic state and food-related motivation.812 Orexin-producing neurons are influenced by appetite-regulating peptide hormones, i.e., inhibited by leptin and activated by ghrelin and low glucose levels. Therefore, it has been suggested that orexin neurons sense the metabolic and nutritional status of the individual and integrate this information to evoke the level of arousal necessary to maintain the energy balance.13 In orexin-deficient narcolepsy patients this homeostatic process may be disrupted, as a possible mechanism in their weight gain. So far, findings of metabolic abnormalities in narcolepsy patients are inconsistent however.5,1418 Previous studies using questionnaires to assess eating behavior abnormalities in narcolepsy patients have led to conflicting results, possibly caused by confounds such as social desirable bias and under reporting.

To overcome these challenges, we employed an innovative cognitive behavioral design to examine food-related behavior and food intake in narcolepsy type 1. Based on the homeostatic effects of orexin and reports of eating disorder symptoms in narcolepsy, we hypothesized that, in situations where food or snacks are readily available, impaired homeostatic signaling and decreased control on eating behavior in narcolepsy is accompanied by continued snack intake in the absence of hunger. To test this hypothesis, we used sensory-specific satiety to change the value of a specific, i.e. sweet or salty, food in a computerized food choice task.19 Previous studies have used sensory-specific satiety to show that participants make fewer responses to obtain a devalued food outcome relative to a still valued one.2023 We predicted that patients with narcolepsy are less sensitive to the effects of changing satiety, leading to continued preference for a devalued food on which they are satiated. Moreover, after the food choice task, we assessed spontaneous ad libitum snack intake and expected this to be enhanced relative to individuals with normal orexin levels. To partly control for possible sleep disorder-related processes (such as alertness and medication-withdrawal), we included an additional group of patients with idiopathic hypersomnia.

METHODS

Participants

Patients were recruited from the outpatient clinics of Sleep Medicine Center Kempenhaeghe (Heeze, the Netherlands), SEIN Sleep-wake Center ‘Heemstede’ (Heemstede, the Netherlands) and through advertisement by the Dutch narcolepsy patients' organization. All patients met the diagnostic criteria of the International Classification of Sleep Disorders, Third Edition (ICSD-3).

We included 24 patients with narcolepsy type-1 (also known as narcolepsy with cataplexy [NC]). All had clear-cut cataplexy, a low mean sleep latency (< 8 min) measured with the Multiple Sleep Latency Test (MSLT) and ≥ 2 sleep onset REM periods (SOREMPs) during MLST naps and the previous night's diagnostic sleep study. In 13 patients, orexin cerebrospinal fluid levels were known and shown to be ≤ 110 pg/mL.

Patients with idiopathic hypersomnia (n = 14, [IH]) all had clear excessive daytime sleepiness and a mean sleep latency at the MSLT ≤ 8 min, and the symptoms could not be explained by another sleep disorder.

Healthy control (HC) participants were recruited via poster and word-of-mouth advertisements in Nijmegen and surrounding areas. Healthy controls (n = 19) were matched to the narcolepsy patients on age, gender, BMI, and level of education.

Inclusion criteria were age 18–60 years old, BMI 20–35, and right-handedness. Exclusion criteria were diabetes mellitus, (a history of) clinically significant hepatic, cardiac, renal, cerebrovascular, endocrine, metabolic, or pulmonary disease, uncontrolled hypertension, (a history of) clinically significant neurological or psychiatric disorders and current psychological treatment other than for narcolepsy or idiopathic hypersomnia, deafness, blindness, or sensory-motor handicaps, history of taste or smell impairments, drug, alcohol or gambling addiction in the past 6 months, inadequate command of Dutch language, current strict dieting (i.e. specific diet and/or in treatment with dietician), or food allergy to one of the ingredients used in food rewards.

All participants were recruited on a voluntary basis and gave written informed consent before the start of the study. The study was approved by the Ethical Committee of the Radboud University Medical Center and reported in the acknowledged Dutch Trial register (www.trialregister.nl: TC = 4508).

Procedure

All patients stopped taking medication a week before the study day (see Table 1 for description of medication use). All participants fasted for 5 h before the test session to increase the motivation to win snacks in the food-choice satiety test. The test session took place between 09:00 and 18:00. Timing of the session was matched between groups. Participants visited the Donders Institute for a session that lasted for approximately 3.5 h. The session included 1 h of MRI scanning (results reported elsewhere), the food-choice satiety test and completing questionnaires while having excess to ad libitum snacks.

Table 1.

Demographic and clinical characteristics.

graphic file with name aasm.39.11.1951.t01.jpg

Questionnaires

The Pittsburgh Sleep Quality Index (PSQI24) and the Epworth Sleepiness Scale (ESS25) were administered to all participants to assess nocturnal sleep quality and disturbances, as well as daytime sleepiness over the last month respectively. Attention span was tested with the forward and backward Digit Span test (subscales from the WAIS-IV26). Measures of height and weight were also collected on the day of testing to assess BMI. The short Dutch Healthy Diet–Food Frequency Questionnaire (DHD-FFQ, modified version: 2 components assessing risk for dental caries were dropped27) was administered to assess how well participants followed the Dutch healthy eating guidelines.

Behavioral Tasks

The food-choice satiety task, described by Hogarth and colleagues,23 was employed to measure changes in snack choices after satiety on one of two snacks (Figure 1). The task was presented on a laptop using Presentation software. The task consisted of three phases. During the first phase (training), participants could choose and win sweet and salty snacks by making button presses. During the second phase (devaluation by satiety), participants were sensory-specific satiated on either the sweet or the salty snack. The third phase (test) was identical to the first phase, i.e., participants would make button presses to choose the same snacks, except that during this phase no direct feedback was delivered (i.e., nominal extinction) to prevent that reward outcomes would influence behavior.

Figure 1.

Figure 1

The food-choice satiety task consisted of three phases. First phase: participants could win sweet and salty snacks by making button presses corresponding to those snacks. Second phase: participants were satiated on either the sweet or the salty snack (i.e., sensory-specific satiety). Third phase: participants would make button presses for the same snacks, except that during this phase no direct feedback was delivered (i.e., nominal extinction).

Participants first selected their preferred salty snack (crisps, red bell pepper salty biscuits or cocktail nuts) and sweet snack (wine gums, skittles or chocolate M&M's). Participants received the following instructions explaining the first phase of the task: “you can win your preferred salty or sweet snack by pressing the left or right arrow button on the laptop. You will learn which button represents which snack by trying, but you won't win a snack each time. When the computer screen shows “choose a button” you can push the button of the snack you want. After the task you will receive 1/5 of the snacks you won.” The (deterministic) key-reward assignment was counterbalanced between participants. Each key had only a 50% chance of yielding its respective outcome (a key press can be interpreted as representing the preference of winning the corresponding snack). On non-rewarded trials, the text “You win nothing” was presented. The snack outcomes (i.e., pictures) were presented for 1,500 ms, followed by a random intertrial interval between 1,000 and 2,500 ms prior to the next trial. Training comprised five 16 trial blocks, and each block contained 2 cycles of 8 trials, with a short break (30 s) in between.

After reading the instructions, participants indicated how hungry they were and how much they wanted the snacks on visual analog scales (VAS). After completing the first task phase, participants received and consumed the snacks they won; participants won 5 sweet and 5 salty snacks on average.

In the second task phase, participants were randomly assigned to either satiety on the sweet or salty snack with the following instruction: “we would like you to eat as much of this snack as you can until you are full or don't want to eat it anymore.”

After sensory-specific satiety, the third phase started. This phase was identical to the first phase except that outcomes were omitted from trials and there were 72 trials in total. The following instruction was given: “you will play the same game as before, you can still win the same snacks and the buttons will still be associated with the same snacks. However, the computer will no longer show you whether you won a snack or not. The computer still counts the number of snacks you won and you will receive the snacks after you finished the task.” After the task participants received their snacks (average around 4.5 sweet and 4.5 salty snack) and rated their hunger and snack wanting on VAS.

Spontaneous Snack Intake

After the food-choice satiety task, participants were asked to fill out questionnaires while 4 bowls with a variety of snacks were placed in front of them. The 4 bowls contained crisps, raisins, wine gums and cocktail nuts. Subjects were told that they could eat the snacks if they felt like it.

Data Analysis

Statistical analyses were performed in SPSS version 21 (SPSS, Inc. Chicago, IL). Outliers, identified using the Grubb test (also known as the maximum-normed residual test28), were excluded for further analyses. Hence, 2 HCs were excluded from data analyses because they preferred one snack considerably more than the other snack in the food-choice satiety task. One NC patient was excluded from data analysis because this patient's devaluation effect was considered an outlier by the Grubb test. One idiopathic hypersomnia patient was excluded from analysis because this patient did not want to participate in the sensory-specific satiety procedure.

All outcome measures were tested for normal distribution and homogeneity of variance; all assumptions of parametric data were met. Percentage of button presses for the devalued snack before and after sensory-specific satiety were calculated to test for devaluation effects. We used a Repeated Measurement ANOVA with pre- and post-satiety button presses for the devalued snack as a within-subjects factor and the two groups as a between-subjects factor to test for the main effect of Satiety, main effect of Group and the interaction effect: Satiety * Group(2). Moreover, hunger and wanting ratings for sweet and salty snacks before versus after sensory-specific satiety were entered into a repeated measurement ANOVA as within-subject variables, and Group as between-subjects variables. Correlations between devaluation effect (post-pre) and ratings were conducted with Pearson correlations, two-tailed. Significant differences in correlations between groups were tested with one-sided Fisher r-to-z transformation.

Spontaneous snack intake was measured by weighing the bowls containing a variety of different snacks before and after presenting them to the participants and calculating the number of calories consumed. Group differences in spontaneous snack intake were tested with an ANOVA with spontaneous snack intake as dependent measure and group as independent factor.

Significance level for all statistical tests was set at P = 0.05 and effect sizes (Cohen's d or partial eta squared [η2] are noted). All data are reported as mean and standard deviation.

Our analyses focus on comparing narcolepsy patients with HC. The additional comparisons with our extra control group, i.e., the IH patients, are shortly described under the heading “Control comparisons” in the Results section.

RESULTS

Participant Characteristics

Table 1 summarizes the demographic and clinical characteristics of the participants who were included in the data analysis. NC patients and HC were well matched on sex, age, BMI and education level. Consistent with previous studies,5 the NC patients had a significantly higher BMI than the idiopathic IH patients. Patient groups did not differ in medication type used, daytime sleepiness, and quality of sleep and were—as expected—significantly sleepier than the HC. The digit span did not show differences in working memory between the groups. The patient groups were not different in dietary food patterns, nor impulsivity. However, the HC did differ from the patient groups in that HC followed the Dutch healthy eating guidelines more (measured with the short DHD-FFQ) and were less impulsive.

Devaluation Effect in the Food-Choice Satiety Task

Across both NC and HC groups, our sensory-specific satiety procedure made participants choose the devalued snack less after satiety than before (main Satiety, Table 2). However, this devaluation effect was significantly reduced in NC patients relative to HC (Figure 2; Satiety * Group, Table 2). Testing the devaluation effect (i.e., main Satiety) separately per group revealed that devaluation by satiety led to significantly less button presses for the satiated snack in HC (t18 = 3.391, P = 0.003, d = 0.778), but not in NC (t23 = 1.655, P = 0.111, d = 0.385). This indicates that NC patients did not significantly change their choice for the devalued snack after satiety. These group differences in the devaluation effect were present despite the fact that the number of calories consumed during the sensory-specific satiety procedure was not significantly different between HC and NC patients (Table 2).

Table 2.

Button presses, calories consumed and subjective ratings during food-choice satiety test, as well as spontaneous snack intake after the food-choice satiety test.

graphic file with name aasm.39.11.1951.t02.jpg

Figure 2.

Figure 2

Significant lower devaluation effect for NC compared with controls. *Significant at P < 0.05. In controls, the devaluation by satiety led to significantly less button presses for the satiated snack, but not in NC. Error bars reflect standard errors. NC, narcolepsy with cataplexy patients.

Ratings in the Food-Choice Satiety Task

Across HC and NC, hunger was reported lower after than before the sensory-specific satiety procedure (main Satiety, Table 2). We did observe a larger effect of satiety on hunger feelings in HC than NC (Satiety * Group, Table 2), but both groups reported significant reductions in hunger feelings after satiety (HC: t18 = 7.111, P < 0.001, d = 1.631; NC: t23 = 3.035, P = 0.006, d = 0.617).

Next, we assessed whether changes in hunger ratings during the task would be associated with the devaluation effect. Indeed, the satiety-induced decrease in hunger feelings (before – after satiety) correlated with the decrease in choices for the devalued snack in the HC group (r = 0.478, P = 0.038), but did not significantly correlate in the NC group (r = −0.015, P = 0.945). The correlation showed a trend for differences between the HC and NC (z = 1.61, P = 0.053). Thus, less hunger after satiety was associated with reduced responding for the satiated snack in HC, but this association did not hold for the NC group (Figure 3A).

Figure 3.

Figure 3

Relation between hunger and devaluation. (A) The satiety-induced difference in hunger ratings correlated positively with the devaluation effect (i.e., reduced choice for the satiated snack) in the control group, but did not significantly correlate in the NC group. (B) The satiety-induced difference in wanted ratings correlated positively with the devaluation effect in the control group, but did not significantly correlate in the NC group. *Significant at P < 0.05. NC, narcolepsy with cataplexy patients.

Across and within both groups, reported wanting of the sweet snack was lower after than before satiety (main Satiety, Table 2; HC: t18 = 5.490, P < 0.001, d = 1.261; NC: t23 = 2.439, P = 0.002, d = 0.713). Reported wanting of the salty snack was also lower after than before satiety across groups (main Satiety, Table 2). However, between groups, we did observe more wanting of the salty snack after satiety in NC compared with HC (Satiety * Group, Table 2), although both groups reported significant reductions in wanting of the salty snack after satiety (HC: t18 = 6.249, P < 0.001, d = 1.432; NC: t23 = 5.481, P < 0.001, d = 1.117).

We also tested whether changes in wanting ratings during the task would be associated with the devaluation effect. Correlations between the difference (before – after satiety) in wanting ratings and the devaluation effect showed a similar result as for the hunger ratings. Specifically, in HC, satiety-induced decreases in wanting (across sweet and salty snacks) were associated with decreased choices for the devalued snack (r = 0.679, P = 0.001), but did not significantly correlate in the NC group (r = 0.176, P = 0.411) (Figure 3B). The correlations were significantly different between HC and NC (z = 1.96, P = 0.026). Thus, less wanting after satiety was associated with reduced responding for the satiated snack in HC, and this was significantly different from that in NC who did not show this association (Figure 3).

Spontaneous Snack Intake

After the food-choice satiety task, participants filled out questionnaires and could consume snacks from the bowls placed in front of them. The NC group consumed significantly more than the control group (Table 2 and Figure 4).

Figure 4.

Figure 4

Narcolepsy patients consumed almost four times more calories than controls. *Significant at P < 0.05. Error bars reflect standard errors. NC, narcolepsy with cataplexy patients.

Correlations with Trait Measures

Between the groups, we observed differences in impulsivity, and BMI (Table 1). However, none of these trait measures correlated with the devaluation effect or caloric intake during the food-choice satiety task, not across groups and neither within groups. However, we did observe that impulsivity was positively correlated with spontaneous snack intake in the NC group (r = 0.527, P = 0.008) and not in HC (r = −0.173, P = 0.480); this association was significantly different between the groups (z = 2.27, P = 0.023).

Control Comparisons

To test for possible sleep disorder-related processes (such as alertness and medication-withdrawal), we also compared HC with IH patients. Overall, we found no differences between HC and IH patients (for details see Table S1 in the supplemental material).

Additionally, we tested for specific orexin-deficiency effects by comparing NC patients with IH patients (for details see Table S2 in the supplemental material). We observed that satiety-induced decreases in hunger were to a larger extent associated with an increased devaluation effect in IH than in NC (z = 1.68, P = 0.046), similar to the effects observed for HC versus NC. Also, spontaneous snack intake was significantly higher in NC patients compared with IH patients (F1,37 = 8.929, P = 0.005, d = 1.109), as observed for NC versus HC.

We repeated our analyses in a subset of narcolepsy patients (n = 13) in which orexin levels were available and deficient, and found similar results versus HC (see Data S3 in the supplemental material).

DISCUSSION

We found a significantly reduced impact of food satiety on food choices and subsequent snack intake in narcolepsy patients relative to healthy controls matched for BMI. Specifically, using sensory-specific (i.e., sweet versus salty) satiety in a food-choice test, we found that narcolepsy patients did not adjust their food choices of a snack outcome after being satiated on one of the snacks. In addition, narcolepsy patients showed a strikingly increased spontaneous snack intake relative to controls.

Sensory-specific satiety, as applied in our computer food-choice satiety task, leads to changes in the value of a specific, i.e., sweet or salty, food and normally results in reduced responding to obtain the devalued food outcome relative to a still valued one.2023 We indeed found this effect in control participants, but not in narcolepsy patients. Adjusting behavior appropriately to food deprivation and satiety relies on intact energy homeostatic signaling orchestrated by peptide hormones, such as leptin and ghrelin, or glucose that act on the orexin neurons in the hypothalamus.29 In narcolepsy patients, orexindeficiency could lead to impaired homeostatic signaling, and thus abnormal effects of food devaluation by satiety. Findings of altered homeostatic functioning in narcolepsy have so far been inconclusive. Some studies have found abnormal leptin and ghrelin levels in blood plasma,16,30 whereas others have not.14,17,31 It is unclear whether alterations in homeostatic functioning are a direct cause of orexin depletion or that altered eating behavior in narcolepsy leads to altered homeostatic functioning. However, as orexin is key in communicating homeostatic needs throughout the brain, it is likely that orexin deficiency impairs the possibility to adequately respond to homeostatic signals from the periphery; explaining our results of diminished influence of our selective satiety procedure on food choice and subsequent increased snack intake in narcolepsy patients.

Sensory-specific satiety paradigms have especially been used to measure the balance between goal-directed behavior and habitual behavior.2123 Behavior is defined as being goal-directed when guided by the consequences of a response, i.e., motivational value of the outcome. For example, in our task, being satiated on M&M's would lead to less button presses (i.e., choice) for this specific candy, which would be a goal-directed response as the M&M outcome was devalued by satiation. Habitual behavior is opposed to goal-directed behavior as it is insensitive to the value of the outcome of behavior, but guided by a direct link between stimulus and response. Thus, in our task, pressing the left button because it predicts M&M's, irrespective of being satiated on them, would be a habitual response. Diminished effects of devaluation of one of the food outcomes by satiation in narcolepsy patients could thus also be interpreted as indicative of habitual behavior. Dopamine is important in goal-directed behavior.32 Increased habitual behavior in narcolepsy patients could possibly be explained by the role of orexin in coding rewarding and motivational properties of stimuli by potentiating dopamine signaling.2,3,32,33 Thus, the absence of a devaluation effect in narcolepsy patients might reflect a decrease in dopamine signaling caused by an orexin deficiency, leading to habitual snack intake. Our findings could potentially also be explained by impaired learning of response-outcome associations in narcolepsy patients (i.e., during training). This seems unlikely, however, as a random survey across a subset of participants indicated that 100% was aware of the button-snack outcome association. Moreover, narcolepsy patients spontaneously consumed four times more snacks than the other groups after the food-choice satiety test, which suggests that the diminished devaluation effect in narcolepsy patients is most likely caused by insensitivity to satiety signals and/or loss of goal-directed control.

Interestingly, relative to controls, narcolepsy patients also demonstrated a different correlation between satiety-induced changes in hunger and wanting ratings and the devaluation effect in the choice task. Specifically, as expected, we found that when healthy controls were less hungry or wanted the snack less after satiety, they also chose the devalued snack less often (i.e., showed a stronger devaluation effect). Intriguingly, this was not significant in narcolepsy patients, who showed reduced effects of the selective satiety manipulation on these subjective ratings to begin with. These results suggest that orexin deficiency is associated with a diminished coupling between subjective experiences, such as hunger and wanting, and food choices. Our results are consonant with previous questionnaire studies indicating higher prevalence of binge eating symptoms (eating in the absence of hunger) in narcolepsy patients than in the normal population.7 A previous dietary assessment study using diaries did not find an overall increased snack intake in narcolepsy patients.35 Diary studies are, however, susceptible to a social desirable bias and under-reporting.36 Here, we measured voluntary snack intake unbeknown to the participants, suggesting that our results are less likely to be affected by a social desirability bias.

Narcolepsy patients consumed four times more calories than healthy controls and idiopathic hypersomnia patients, after completing the food-choice satiety task. These findings are reminiscent of previous studies, showing increased intake of high-carbohydrate palatable food as well as decreased dopa-mine signaling and increased opioid signaling after sleep deprivation.37,38 Furthermore, sleep-deprived animals are known to show diminished dopamine-mediated goal-directed behavior to obtain food, but eat more when food is readily available.38 It seems therefore possible that narcolepsy patients suffer from a dysregulation of dopamine and opioid systems similar to effects of sleep loss in healthy subjects.39 However, by including a group of idiopathic hypersomnia patients we could discern general sleep-disorder related issues from orexin-deficiency effects. Indeed, relative to controls, idiopathic hypersomnia patients did not show increased spontaneous snack intake nor abnormal devaluation effects, so it seems unlikely that excessive sleepiness alone would explain our findings of increased snack intake and aberrant food choices after satiety in narcolepsy patients. Furthermore, we observed that the positive correlation between hunger and snack choice after satiety (i.e., a greater reduction in hunger was associated with a greater effect on choice) was enhanced in idiopathic hypersomnia patients relative to narcolepsy patients. These results support our interpretation that orexin deficiency in particular is associated with a diminished coupling between subjective experiences and food choices.

In conclusion, by using an innovative cognitive behavioral approach, we demonstrate for the first time that narcolepsy type 1 patients are less influenced by satiety with respect to food choices and snack intake. These findings may help understand the phenomenon of overweight and obesity in these patients. In addition, this study shows an important role of orexin signaling in food-related reward processing—as previously found in animal studies812—which may have broader implications for the study of human eating behavior.

DISCLOSURE STATEMENT

This was not an industry supported study. This study was supported by a VIDI grant from the Netherlands Organization for Scientific Research awarded to Dr. Overeem (grant no. 016.116.371). Dr. Aarts was supported by a VENI grant from the Netherlands Organization for Scientific Research (NWO) (016.135.023). Dr. Overeem has received research support from UCB Pharma and is on the speakers bureau for UCB Pharma, Boehringer Ingelheim, and Novartis. Dr. Aarts has received research support from Wrigley (Mars Inc.) and Mead Johnson Nutrition. Dr. Lammers has received research support from UCB Pharma and consulted for UCB Pharma, Jazz, and Bioprojet. The other authors have indicated no financial conflicts of interest. The work was performed at the Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.

ACKNOWLEDGMENTS

The authors thank all the patients and their families for participating in our study.

aasm.39.11.1951s1.pdf (151.1KB, pdf)

REFERENCES

  • 1.Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000;355:39–40. doi: 10.1016/S0140-6736(99)05582-8. [DOI] [PubMed] [Google Scholar]
  • 2.Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000;6:991–7. doi: 10.1038/79690. [DOI] [PubMed] [Google Scholar]
  • 3.Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet. 2007;369:499–511. doi: 10.1016/S0140-6736(07)60237-2. [DOI] [PubMed] [Google Scholar]
  • 4.Kok SW, Overeem S, Visscher TL, et al. Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity. Obes Res. 2003;11:1147–54. doi: 10.1038/oby.2003.156. [DOI] [PubMed] [Google Scholar]
  • 5.Schuld A, Hebebrand J, Geller F, Pollmächer T. Increased body-mass index in patients with narcolepsy. Lancet. 2000;355:1274–5. doi: 10.1016/S0140-6736(05)74704-8. [DOI] [PubMed] [Google Scholar]
  • 6.Chabas D, Foulon C, Gonzalez J, et al. Eating disorder and metabolism in narcoleptic patients. Sleep. 2007;30:1267–73. doi: 10.1093/sleep/30.10.1267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fortuyn HAD, Swinkels S, Buitelaar J, et al. High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study. Sleep. 2008;31:335–41. doi: 10.1093/sleep/31.3.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Harris GC, Aston-Jones G. Arousal and reward: a dichotomy in orexin function. Trends Neurosci. 2006;29:571–7. doi: 10.1016/j.tins.2006.08.002. [DOI] [PubMed] [Google Scholar]
  • 9.Aston-Jones G, Smith RJ, Moorman DE, Richardson KA. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology. 2009;56(Suppl 1):112–21. doi: 10.1016/j.neuropharm.2008.06.060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Mahler S V, Moorman DE, Smith RJ, James MH, Aston-Jones G. Motivational activation: a unifying hypothesis of orexin/hypocretin function. Nat Neurosci. 2014;17:1298–303. doi: 10.1038/nn.3810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ. Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U S A. 2008;105:19480–5. doi: 10.1073/pnas.0808023105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sakurai T. The role of orexin in motivated behaviours. Nat Rev Neurosci. 2014;15:719–31. doi: 10.1038/nrn3837. [DOI] [PubMed] [Google Scholar]
  • 13.Cone JJ, McCutcheon JE, Roitman MF. Ghrelin acts as an interface between physiological state and phasic dopamine signaling. J Neurosci. 2014;34:4905–13. doi: 10.1523/JNEUROSCI.4404-13.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Donjacour CEHM, Pardi D, Aziz NA, et al. Plasma total ghrelin and leptin levels in human narcolepsy and matched healthy controls: basal concentrations and response to sodium oxybate. J Clin Sleep Med. 2013;9:797–803. doi: 10.5664/jcsm.2924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Poli F, Plazzi G, Di Dalmazi G, et al. Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep. 2009;32:1491–7. doi: 10.1093/sleep/32.11.1491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kok SW, Meinders AE, Overeem S, et al. Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J Clin Endocrinol Metab. 2002;87:805–9. doi: 10.1210/jcem.87.2.8246. [DOI] [PubMed] [Google Scholar]
  • 17.Dahmen N, Engel A, Helfrich J, et al. Peripheral leptin levels in narcoleptic patients. Diabetes Technol Ther. 2007;9:348–53. doi: 10.1089/dia.2006.0037. [DOI] [PubMed] [Google Scholar]
  • 18.Arnulf I, Lin L, Zhang J, et al. CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency? Sleep. 2006;29:1017–24. doi: 10.1093/sleep/29.8.1017. [DOI] [PubMed] [Google Scholar]
  • 19.Rolls BJ, Rolls ET, Rowe EA, Sweeney K. Sensory specific satiety in man. Physiol Behav. 1981;27:137–42. doi: 10.1016/0031-9384(81)90310-3. [DOI] [PubMed] [Google Scholar]
  • 20.Balleine BW, O'Doherty JP. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology. 2010;35:48–69. doi: 10.1038/npp.2009.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tricomi E, Balleine BW, O'Doherty JP. A specific role for posterior dorsolateral striatum in human habit learning. Eur J Neurosci. 2009;29:2225–32. doi: 10.1111/j.1460-9568.2009.06796.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Valentin V V, Dickinson A, O'Doherty JP. Determining the neural substrates of goal-directed learning in the human brain. J Neurosci. 2007;27:4019–26. doi: 10.1523/JNEUROSCI.0564-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hogarth L, Chase HW, Baess K. Impaired goal-directed behavioural control in human impulsivity. Q J Exp Psychol. 2012;65:305–16. doi: 10.1080/17470218.2010.518242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213. doi: 10.1016/0165-1781(89)90047-4. [DOI] [PubMed] [Google Scholar]
  • 25.Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest. 1993;103:30–6. doi: 10.1378/chest.103.1.30. [DOI] [PubMed] [Google Scholar]
  • 26.Kaufman AS, Kaufman NL. Cambridge University Press; 2001. Specific learning disabilities and difficulties in children and adolescents: psychological assessment and evaluation. [Google Scholar]
  • 27.van Lee L, Geelen A, van Huysduynen E, de Vries JHM, van't Veer P, Feskens EJM. The Dutch Healthy Diet index (DHD-index): an instrument to measure adherence to the Dutch Guidelines for a Healthy Diet. Nutr J. 2012;11:49. doi: 10.1186/1475-2891-11-49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Barnett V, Lewis T. Outliers in statistical data. J Wiley & Sons. 1994 [Google Scholar]
  • 29.Sheng Z, Santiago AM, Thomas MP, Routh VH. Metabolic regulation of lateral hypothalamic glucose-inhibited orexin neurons may influence midbrain reward neurocircuitry. Mol Cell Neurosci. 2014;62:30–41. doi: 10.1016/j.mcn.2014.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Schuld A, Blum WF, Pollmächer T. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol. 2002;51:660. doi: 10.1002/ana.10164. author reply 660-1. [DOI] [PubMed] [Google Scholar]
  • 31.Heier MS, Jansson TS, Gautvik KM. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy. J Clin Sleep Med. 2011;7:653–8. doi: 10.5664/jcsm.1474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.de Wit S, Watson P, Harsay H a, Cohen MX, van de Vijver I, Ridderinkhof KR. Corticostriatal connectivity underlies individual differences in the balance between habitual and goal-directed action control. J Neurosci. 2012;32:12066–75. doi: 10.1523/JNEUROSCI.1088-12.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci. 2003;23:7–11. doi: 10.1523/JNEUROSCI.23-01-00007.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.España RA, Melchior JR, Roberts DCS, Jones SR. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology (Berl) 2011;214:415–26. doi: 10.1007/s00213-010-2048-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lammers GJ, Pijl H, Iestra J, Langius JA, Buunk G, Meinders AE. Spontaneous food choice in narcolepsy. Sleep. 1996;19:75–6. doi: 10.1093/sleep/19.1.75. [DOI] [PubMed] [Google Scholar]
  • 36.Subar AF. Using Intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol. 2003;158:1–13. doi: 10.1093/aje/kwg092. [DOI] [PubMed] [Google Scholar]
  • 37.Nedeltcheva A V, Kilkus JM, Imperial J, Kasza K, Schoeller DA, Penev PD. Sleep curtailment is accompanied by increased intake of calories from snacks. Am J Clin Nutr. 2009;89:126–33. doi: 10.3945/ajcn.2008.26574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hanlon EC, Benca RM, Baldo BA, Kelley AE. REM sleep deprivation produces a motivational deficit for food reward that is reversed by intra-accumbens amphetamine in rats. Brain Res Bull. 2010;83:245–54. doi: 10.1016/j.brainresbull.2010.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Baldo BA, Hanlon EC, Obermeyer W, Bremer Q, Paletz E, Benca RM. Upregulation of gene expression in reward-modulatory striatal opioid systems by sleep loss. Neuropsychopharmacology. 2013;38:2578–87. doi: 10.1038/npp.2013.174. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

aasm.39.11.1951s1.pdf (151.1KB, pdf)

RESOURCES

OSZAR »